Comparison of autologous platelet-rich plasma (PRP) with protokine (ASC)

Comparison of intrauterine injection of autologous platelet-rich plasma with protokine on the outcome of embryo transfer in infertile women with recurrent implantation failure

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250924067348N1

Enrollment

Registered

2025-10-10

Start date

2025-11-21

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile women with repeated implantation failure.

Interventions

Intervention 1: Intervention group: Platelet-rich plasma (PRP). Intervention 2: Intervention group: Autologous Conditioned Serum.

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Samples are selected from patients who have referred to the Fatimah Infertility Center due to RIF and are candidates for the frozen embryo transfer process.

Exclusion criteria

Exclusion criteria: Male-caused infertility, PCOS women

Design outcomes

Primary

Measure	Time frame
Biochemical pregnancy. Timepoint: Day 14 after transfer. Method of measurement: Laboratory using the ELISA method.;Clinical pregnancy. Timepoint: Day 28 after transfer. Method of measurement: Ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh

Hamedan University of Medical Sciences

rozhinaghorbani@yahoo.com0098818277012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026